Related Experiment Video
Updated: May 30, 2026
08:06
The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
Current trends in β-lactam based β-lactamases inhibitors
1Innovative Solution, via Copernico 22, 20016 Pero, Italy.
Current Medicinal Chemistry
|August 16, 2011
Summary
Antibiotic resistance is a growing threat. This review surveys new beta-lactamase inhibitors developed between 2006-2010 to combat resistant bacteria.
Area of Science:
- Microbiology
- Pharmacology
- Medicinal Chemistry
Background:
- Antibiotic resistance, driven by bacterial resistance mechanisms like beta-lactamases, poses a significant global health threat.
- The emergence of diverse beta-lactamases (e.g., ESBLs, AmpC, KPC, VIMs, IMPs, NDM-1) has led to resistance against multiple antibiotic classes.
- Increasing carbapenem use has exacerbated resistance, particularly in Acinetobacter spp.
Purpose of the Study:
- To provide a comprehensive survey of novel beta-lactamase inhibitors.
- To review inhibitors discovered in the scientific and patent literature from 2006 to 2010.
- To highlight recent advancements in combating antibiotic resistance.
Main Methods:
- Systematic literature review of patent and scientific publications.
- Focus on beta-lactamase inhibitors identified between 2006 and 2010.
- Analysis of emerging resistance mechanisms and therapeutic strategies.
Main Results:
- Identification of novel beta-lactamase inhibitors developed during the specified period.
- The pharmaceutical industry's renewed interest in developing new beta-lactamase inhibitors.
- Emergence of inhibitors designed for combination therapy with existing or novel beta-lactam antibiotics.
Conclusions:
- The period 2006-2010 saw significant efforts in discovering new beta-lactamase inhibitors.
- These inhibitors are crucial for overcoming antibiotic resistance, particularly against Gram-negative bacteria.
- Combination therapies involving beta-lactamase inhibitors represent a promising strategy to restore the efficacy of beta-lactam antibiotics.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...